PGHH Reports Strong Q1 FY26 Profit Growth; EPS Jumps to ₹59.17
The substantial increase in profitability and EPS indicates strong financial performance and is likely to have a significant positive impact on investor perception and the company's valuation.
The company reported a significant year-on-year increase in both profit before tax (nearly double) and profit for the period, alongside a substantial jump in Basic EPS for the quarter ended June 30, 2025.
* Procter & Gamble Hygiene and Health Care Limited's Board of Directors approved the unaudited financial results for the quarter ended June 30, 2025, in a meeting held on July 30, 2025. * The company reported a revenue from operations of ₹937.03 crore for the quarter ended June 30, 2025, a slight increase from ₹931.75 crore in the corresponding quarter of the previous year (ended June 30, 2024). * Profit before tax for the quarter significantly increased to ₹264.70 crore from ₹112.28 crore in the same period last year. * Profit for the period also saw a substantial rise, reaching ₹192.06 crore compared to ₹81.06 crore in the quarter ended June 30, 2024. * Basic Earnings per Share (EPS) for the quarter stood at ₹59.17, a notable increase from ₹24.97 reported in the corresponding previous year quarter. * The company re-submitted these unaudited financial results on August 2, 2025, as the initial submission on July 30, 2025, was inadvertently not in a machine-readable format. * It was noted that the company's financial year end was changed from June 30th to March 31st, effective from the previous financial year 2024-25, which covered a nine-month period from July 1, 2024, to March 31, 2025.
What to do with a filing like this
Procter & Gamble Hygiene and Health Care Limited filed this with the NSE as a statutory disclosure, categorised under results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Procter & Gamble Hygiene and Health Care Limited. Read the original for the full detail.